Grifols SA ADR

Stock Chart, Company Information, and Scan Results

$7.08(as of Jul 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Grifols SA ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$7.08
Ticker SymbolGRFS
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees25,000
CountyUSA
Market Cap$4,818.5M
EBIDTA1,676.2M
10-Day Moving Average7.28
P/E Ratio11.60
20-Day Moving Average7.39
Forward P/E Ratio8.16
50-Day Moving Average7.76
Earnings per Share0.69
200-Day Moving Average8.67
Profit Margin4.29%
RSI34.63
Shares Outstanding258.2M
ATR0.19
52-Week High10.96
Volume1,099,997
52-Week Low7.06
Most Recent Support Level7.08
Book Value7,855.2M
Most Recent Resistance Level7.49
P/B Ratio0.61
Upper Keltner7.82
P/S Ratio0.65
Lower Keltner6.96
Debt-to-Equity Ratio7.82
Next Earnings Date07/27/2026
Cash Surplus-1,423.5M
Next Ex-Dividend DateUnknown

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Grifols SA ADR In Our Stock Scanner

As of Jul 02, 2026
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.